Ann: Bodyguard Results, page-176

Well Professor Wright commented that the results were very positive and that BG was at least equivalent to the gold standard topical non-steroidal, very impressive. He then goes on to say that there is an opportunity for further development and evaluation over a longer time frame so I don't believe it is due to the irritation.

When i read this I immediately thought of the eye wand and how we were lead to believe that it was a hard launch (well at least I did anyway). If there are further tweaks will there be another clinical trial? Professor Wrights comments certainly doesn't sound like the BG product is sign sealed delivered, its rather perplexing. Will P&G sign on the dotted lines when Professor Wright says there is an opportunity to further develop the product?